top of page

DİĞER YAYINLAR

logo.png

  1. Buyuktas D, Acar K, Sucak G, Toptas T, Kapucu I, Bekoz H, Erdem S, Nalcaci M, Atalay F, Akay MO, Ferhanoglu B. COVID-19 infection in patients with acute leukemia; Istanbul experience. Am J Blood Res 2021;11:427-437.
     

  2. Uncu Ulu B, Dal MS, Yonal Hindilerden I, Akay OM, Mehtap O, Buyukkurt N, Hindilerden F, Gunes AK, Yigenoglu TN, Basci S, Kizil Cakar M, Yanardag Acik D, Korkmaz S, Ulas T, Ozet G, Ferhanoglu B, Nalcaci M, Altuntas F. Brentuximab vedotin and bendamustine: an effective salvage therapy for relapsed or refractory Hodgkin lymphoma patients. J Chemother 2021:1-9.
     

  3. Tombak A, Pepedil Tanrikulu F, Durusoy SS, Dincyurek HD, Kaya E, Umit EG, Yavasoglu I, Mehtap O, Deveci B, Ozcan MA, Terzi H, Okay M, Sayinalp N, Yilmaz M, Okan V, Kizikli A, Ozcan O, Cetin G, Demircioglu S, Aydogdu I, Saydam G, Davulcu EA, Ilhan G, Ucar MA, Ozet G, Akpinar S, Turgut B, Berber I, Kurtoglu E, Sonmez M, Batur DS, Yildirim R, Ozkocamaz V, Gunes AK, Sahip B, Ertop S, Akay OM, Basturk A, Dogu MH, Akdeniz A, Unal A, Seyhanli A, Gurkan E, Cekdemir D, Ferhanoglu B. Efficacy and Safety of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia: Retrospective Analysis of Real-Life Data. Turk J Haematol 2021;38:273-285.
     

  4. Kastritis E, Palladini G, Minnema MC, Wechalekar AD, Jaccard A, Lee HC, Sanchorawala V, Gibbs S, Mollee P, Venner CP, Lu J, Schonland S, Gatt ME, Suzuki K, Kim K, Cibeira MT, Beksac M, Libby E, Valent J, Hungria V, Wong SW, Rosenzweig M, Bumma N, Huart A, Dimopoulos MA, Bhutani D, Waxman AJ, Goodman SA, Zonder JA, Lam S, Song K, Hansen T, Manier S, Roeloffzen W, Jamroziak K, Kwok F, Shimazaki C, Kim JS, Crusoe E, Ahmadi T, Tran N, Qin X, Vasey SY, Tromp B, Schecter JM, Weiss BM, Zhuang SH, Vermeulen J, Merlini G, Comenzo RL, Investigators AT. Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis. The New England journal of medicine 2021;385:46-58.
     

  5. Demirkol MO, Ozkan A, Ucar B, Wester HJ, Ferhanoglu B. Extramedullary Relapsed Multiple Myeloma Treatment With 177Lu-Labeled CXCR4 Endoradiotherapy and Dosimetric Results. Clin Nucl Med 2021;46:656-658.
     

  6. Somay K, Copur S, Osmanbasoglu E, Masyan H, Arslan H, Akay OM, Tekin S, Ferhanoglu B. Hiv-Associated Non Hodgkin Lymphoma: A Case Series Study from Turkey. Afr J Infect Dis 2020;14:42-47.
     

  7. Saglam B, Kalyon H, Ozbalak M, Ornek S, Keske S, Tabak L, Cakar N, Zeren H, Aytekin S, Bolukbasi Y, Ferhanoglu B. Bortezomib induced pulmonary toxicity: a case report and review of the literature. Am J Blood Res 2020;10:407-415.
     

  8. Sezer H, Yazici D, Tezelman S, Demirkol MO, Unal OF, Dilege S, Taskin OC, Peker O, Kapran Y, Colakoglu B, Aygun MS, Ferhanoglu B, Alagol F. Concomittant occurence of well-differentiated thyroid carcinoma metastasis and chronic lymphocytic leukemia in the same lymph node along with internal jugular vein thrombus: a case report. Indian J Pathol Microbiol 2021;64:149-151.
     

  9. Atalar SC, Akay OM, Osmanbasoglu E, Masyan H, Taskin OC, Ferhanoglu B. Intravascular Large B-Cell Lymphoma Within the Appendix Presenting as Acute Abdomen: A Challenging Diagnosis for Hematologists. Turk J Haematol 2021;38:89-91.
     

  10. Kalyon H, Ozturk E, Tuzlali S, Akay OM, Ferhanoglu B. Breast Implant-Associated Anaplastic Large-Cell Lymphoma: A Case Report. Turkish journal of haematology : official journal of Turkish Society of Haematology. 2019; 36(4): 296-9.
     

  11. Ozyigit LP, Aktas EC, Senbas ZA, Ozturk AB, Ozturk E, Ergonul MO, Tabak L, Ferhanoglu B, Cetiner M, Deniz G. The role of atopy in the pathogenesis of bleomycin pulmonary toxicity. Respiratory medicine. 2019; 155: 1-5.
     

  12. Younes A, Brody J, Carpio C, Lopez-Guillermo A, Ben-Yehuda D, Ferhanoglu B, Nagler A, Ozcan M, Avivi I, Bosch F, Caballero Barrigon MD, Hellmann A, Kuss B, Ma DDF, Demirkan F, Yagci M, Horowitz NA, Marlton P, Cordoba R, Wrobel T, Buglio D, Streit M, Hodkinson BP, Schaffer M, Alvarez J, Ceulemans R, Balasubramanian S, de Jong J, Wang SS, Fourneau N, Jurczak W. Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a study. The Lancet Haematology. 2019; 6(2): e67-e78
     

  13. Ferhanoglu B, Ozturk E, Ozbalak M. Venetoclax-Rituximab in Chronic Lymphocytic Leukemia. The New England journal of medicine. 2018; 378(22): 2141-2.
     

  14. Ozturk E, Akay MO, Ferhanoglu B. Recognizing Pinch Purpura as the First Manifestation of Light-chain Amyloidosis. Turk J Haematol. 2018; 35(3): 208-9.
     

  15. Mateos MV, Dimopoulos MA, Cavo M, Suzuki K, Jakubowiak A, Knop S, Doyen C, Lucio P, Nagy Z, Kaplan P, Pour L, Cook M, Grosicki S, Crepaldi A, Liberati AM, Campbell P, Shelekhova T, Yoon SS, Iosava G, Fujisaki T, Garg M, Chiu C, Wang J, Carson R, Crist W, Deraedt W, Nguyen H, Qi M, San-Miguel J, Investigators AT. Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma. The New England journal of medicine. 2018; 378(6): 518-28.
     

  16. Madran B, Keske S, Tokca G, Donmez E, Ferhanoglu B, Cetiner M, Mandel NM, Ergonul O. Implementation of an antimicrobial stewardship program for patients with febrile neutropenia. American journal of infection control. 2018; 46(4): 420-4.
     

  17. Ozturk E, Ozyigit LP, Ozturk AB, Akay MO, Cetiner M, Ferhanoglu B. Rituximab desensitization in three patients with severe rituximab allergy. Current problems in cancer. 2017; 41(5): 349-54.
     

  18. Ozbalak M, Torun ES, Ozdemirli M, Ucar AR, Akpinar TS, Tascioglu C, Ferhanoglu B. Inflammatory myofibroblastic tumor mimicking a relapse in a patient with Hodgkin's lymphoma: report of an unusual case and review of the literature. Clinical case reports. 2017; 5(6): 945-9.
     

  19. Falay O, Ozturk E, Bolukbasi Y, Gumus T, Ornek S, Ozbalak M, Cetiner M, Demirkol O, Ferhanoglu B. Use of fluorodeoxyglucose positron emission tomography for diagnosis of bleomycin-induced pneumonitis in Hodgkin lymphoma. Leuk Lymphoma. 2017; 58(5): 1114-22.
     

  20. Bekoz HS, Kantarcioglu B, Tecimer T, Uskent N, Cetiner M, Ferhanoglu B, Sargin D. Complete Remission of Burkitt Lymphoma After Surgical Excision: A Case Report. Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion. 2016; 32(Suppl 1): 178-80.
     

  21. Salim O, Toptas T, Avsar E, Yucel OK, Ozturk E, Ferhanoglu B, Geduk A, Mehtap O, Tombak A, Tiftik EN, Deveci B, Kurtoglu E, Kara O, Atagunduz IK, Tuglular TF, Undar L. Azacitidine versus decitabine in patients with refractory anemia with excess blast-Results of multicenter study. Leuk Res. 2016; 45: 82-9.
     

  22. Tekgunduz E, Sencan I, Kapuagasi A, Unal D, Ozturk M, Gumus E, Goker H, Tavil EB, Ertem M, Cetin M, Arat M, Soysal T, Karakasli O, Sur HY, Yesilipek A, Ferhanoglu B, Uckan D, Ilhan O, Altuntas F. Hematopoietic cell transplantation activity of Turkey in 2014: Ongoing increase in HCT rates. Transfus Apher Sci. 2016.
     

  23. Tanrikulu Simsek E, Eskazan AE, Cengiz M, Ar MC, Ekizoglu S, Salihoglu A, Gulturk E, Elverdi T, Ongoren Aydin S, Senem Demiroz A, Buyru AN, Baslar Z, Ozbek U, Ferhanoglu B, Aydin Y, Tuzuner N, Soysal T. Imatinib reduces bone marrow fibrosis and overwhelms the adverse prognostic impact of reticulin formation in patients with chronic myeloid leukaemia. J Clin Pathol. 2016.
     

  24. Yemisen M, Balkan, II, Salihoglu A, Eskazan AE, Mete B, Ar MC, Ongoren S, Baslar Z, Ozaras R, Saltoglu N, Mert A, Ferhanoglu B, Ozturk R, Tabak F, Soysal T. The Changing Epidemiology of Blood Stream Infections and Resistance in Haematopoietic Stem Cell Transplantation Recipients. Turk J Haematol. 2015.
     

  25. Ozturk E, Ozbalak M, Berk S, Erdogan I, Avsar E, Dolgun A, Cetiner M, Mandel NM, Yalniz FF, Elverdi T, Salihoglu A, Eskazan AE, Ar MC, Ongoren S, Baslar Z, Aydin Y, Soysal T, Ferhanoglu B. Comparison of International Prognostic Index and NCCN-IPI in 324 patients with de novo diffuse large B-cell lymphoma: a multi-center retrospective analysis. Leuk Lymphoma. 2015: 1-4.
     

  26. Offner F, Samoilova O, Osmanov E, Eom HS, Topp MS, Raposo J, Pavlov V, Ricci D, Chaturvedi S, Zhu E, van de Velde H, Enny C, Rizo A, Ferhanoglu B. Frontline rituximab, cyclophosphamide, doxorubicin, and prednisone with bortezomib (VR-CAP) or vincristine (R-CHOP) for non-GCB DLBCL. Blood. 2015; 126(16): 1893-901.
     

  27. Islak Mutcali S, Saltoglu N, Balkan, II, Ozaras R, Yemisen M, Mete B, Tabak F, Mert A, Ozturk R, Ongoren S, Baslar Z, Aydin Y, Ferhanoglu B, Soysal T. Early Changes of Mannose Binding Lectin, H-ficolin and Procalcitonin in Patients With Febrile Neutropenia: A Prospective, Observational Study. Turk J Haematol. 2015.
     

  28. Demirel A, Tabak F, Ar MC, Mete B, Ongoren S, Yemisen M, Ozaras R, Eskazan AE, Baslar Z, Mert A, Soysal T, Ferhanoglu B, Aydin Y, Ozturk R. Secondary Infections in Febrile Neutropenia in Hematological Malignancies: More Than Another Febrile Neutropenic Episode. Turk J Haematol. 2015.
     

  29. Aydin SO, Eskazan AE, Berk S, Erdogan I, Yalniz FF, Elverdi T, Salihoglu A, Ar MC, Baslar Z, Soysal T, Ferhanoglu B, Tuzuner N, Aydin Y. Retrospective Evaluation of 83 Patients with Hairy Cell Leukemia Treated with 3 Different Treatment Modalities in the Last Two Decades: A Single Center Experience. Haematologica. 2015; 100: 424-5.
     

  30. Tokmak H, Ergonul O, Demirkol O, Cetiner M, Ferhanoglu B. Diagnostic contribution of (18)F-FDG-PET/CT in fever of unknown origin. Int J Infect Dis. 2014; 19: 53-8.
     

  31. Soysal T, Salihoglu A, Esatoglu SN, Gulturk E, Eskazan AE, Hatemi G, Hatemi I, Aydin SO, Erzin YZ, Baslar Z, Tuzuner N, Ferhanoglu B, Celik AF. Bone marrow transplantation for Behcet's disease: a case report and systematic review of the literature. Rheumatology. 2014; 53(6): 1136-41.
     

  32. Ferhanoglu B, Salihoglu A, Elverdi T, Karadogan I, Ozdemir E, Erdem G, Karadurmus N, Akyol G, Kaynar L, Yegin A, Sucak G, Ozkocaman V, Topcuoglu P, Ozcan M, Birtas E, Goker H, Baslar Z, Paydas S. Brentuximab Vedotin for Relapsed or Refractory Hodgkin Lymphoma: Experience in Turkey. Haematologica. 2014; 99: 675-6.
     

  33. Eskazan AE, Eyice D, Kurt EA, Elverdi T, Yalniz FF, Salihoglu A, Ar MC, Ongoren Aydin S, Baslar Z, Ferhanoglu B, Aydin Y, Tuzuner N, Ozbek U, Soysal T. Chronic myeloid leukemia patients who develop grade I/II pleural effusion under second-line dasatinib have better responses and outcomes than patients without pleural effusion. Leuk Res. 2014; 38(7): 781-7.
     

  34. Cetin G, Eskazan AE, Ar MC, Aydin SO, Ferhanoglu B, Soysal T, Baslar Z, Aydin Y. Bone-Specific Alkaline Phosphatase Levels among Patients with Multiple Myeloma Receiving Various Therapy Options. Turk J Haematol. 2014; 31(4): 374-80.
     

  35. Berk S, Ozgur N, Yalniz FF, Elverdi T, Salihoglu A, Eskazan AE, Ar MC, Baslar Z, Soysal T, Ferhanoglu B, Tuzuner N, Aydin Y, Aydin SO. Primary Gastointestinal Non-Hodgkin's Lymphoma: Retrospective Evaluation of 50 Patients. Haematologica. 2014; 99: 694-.
     

  36. Ardeshna KM, Qian W, Smith P, Braganca N, Lowry L, Patrick P, Warden J, Stevens L, Pocock CF, Miall F, Cunningham D, Davies J, Jack A, Stephens R, Walewski J, Ferhanoglu B, Bradstock K, Linch DC. Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial. Lancet Oncol. 2014; 15(4): 424-35.
     

  37. Yilmaz M, Eskazan AE, Unsal A, Taninmis H, Kara E, Cetiner M, Ferhanoglu B. Cyclosporin A therapy on idiopathic thrombotic thrombocytopenic purpura in the relapse setting: two case reports and a review of the literature. Transfusion. 2013; 53(7): 1586-93.
     

  38. Tokmak H, Ergonul O, Demirkol O, Cetiner M, Ferhanoglu B. Diagnostic Contribution of F-18 FDG-PET/CT on the Management of FUO. Eur J Nucl Med Mol I. 2013; 40: S138-S.
     

  39. Salihoglu A, Ozbalak M, Keskin D, Tecimer T, Soysal T, Ferhanoglu B. An unusual presentation of a chronic lymphocytic leukemia patient with 17p deletion after reduced-intensity transplantation: Richter syndrome and concomitant graft-versus-host disease--case report. Transplant Proc. 2013; 45(7): 2845-8.
     

  40. Salihoglu A, Hatemi I, Senel TE, Aki H, Ferhanoglu B. Massive gastrointestinal bleeding during the course of chronic myelomonocytic leukemia. J Gastrointestin Liver Dis. 2013; 22(1): 7.
     

  41. Sahin F, Saydam G, Comert M, Uz B, Yavuz AS, Turan E, Yonal I, Atay H, Keltikli E, Turgut M, Pehlivan M, Akay MO, Gurkan E, Paydas S, Kahraman S, Demirkan F, Kirkizlar O, Akpinar S, Pamuk GE, Demir M, Ozbas HM, Sonmez M, Gulturk M, Salihoglu A, Eskazan AE, Ar C, Haydaroglu Sahin H, Ongoren S, Baslar Z, Aydin Y, Yenere MN, Tuzuner N, Ferhanoglu B, Haznedaroglu IC, Ilhan O, Soysal T. Turkish Chronic Myeloid Leukemia Study: Retrospective Sectional Analysis of CML Patients. Turk J Haematol. 2013; 30(4): 351-8.
     

  42. Ozbalak M, Tokatli I, Ozdemirli M, Tecimer T, Ar MC, Ornek S, Koroglu A, Laleli Y, Ferhanoglu B. Is valganciclovir really effective in primary effusion lymphoma: case report of an HIV(-) EBV(-) HHV8(+) patient. Eur J Haematol. 2013; 91(5): 467-9.
     

  43. Ozbalak M, Ar MC, Tuzuner N, Salihoglu A, Eskazan AE, Ongoren Aydin S, Baslar Z, Soysal T, Aydin Y, Barak Dolgun A, Ergonul O, Ferhanoglu B. Detailed analysis of diffuse large B cell lymphoma patients: a single-center, retrospective study. ISRN Hematol. 2013; 2013: 908191.
     

  44. Erbilgin Y, Eskazan AE, Ng OH, Salihoglu A, Elverdi T, Firtina S, Tatonyan SC, Aydin SO, Ar MC, Baslar Z, Sayitoglu M, Ferhanoglu AB, Aydin Y, Ozbek U, Soysal T. Next-Generation Sequencing Of The BCR-ABL1 Domain May Be Beneficial In Decision Making Among Chronic Myeloid Leukemia Patients With Tyrosine Kinase Inhibitor Resistance. Blood. 2013; 122(21).
     

  45. Aki H, Uzunaslan D, Saygin C, Demir H, Salihoglu A, Ferhanoglu B, Tuzuner N. Clinicopathologic features of primary thyroid lymphomas: A single center experience. Virchows Arch. 2013; 463(2): 151-.
     

  46. Selcukbiricik F, Tural D, Elicin O, Berk S, Ozguroglu M, Bese N, Ferhanoglu B. Primary gastric lymphoma: conservative treatment modality is not inferior to surgery for early-stage disease. ISRN Oncol. 2012; 2012: 951816.
     

  47. Ferhanoglu B, Ozbalak M. Diffüz Büyük B Hücreli Lenfoma (Article published in Turkish, Title: Diffuse Large B Cell Lymphoma). HematoLog-Special Issue on Lymphoma. 2013; 3(2): 355-81.
     

  48. Ferhanoglu B, Ozbalak M. Primer Merkezi Sinir Sistemi Lenfomaları (Article published in Turkish, Title: Primary Central Nervous System Lymphomas). HematoLog-Special Issue on Lymphoma. 2013; 3(2): 382-94.
     

  49. Ozturk M, Ozaydin S, Oyan B, Ozbalak M, Arpaci F, Paydas S, Ataergin S, Ferhanoglu B, Kocak N, Gurkan E, Ozet A, Barista I. The comparison of up-front autologous peripheral stem cell transplantation in first remission and long-lasting intensive chemotherapy protocols in highly aggressive non-Hodgkin's lymphomas: Results of a retrospective analysis. J Clin Oncol. 2012; 30(15).
     

  50. Ozbalak M, Cetiner M, Bekoz H, Atesoglu EB, Ar C, Salihoglu A, Tuzuner N, Ferhanoglu B. Azacitidine has limited activity in 'real life' patients with MDS and AML: a single centre experience. Hematol Oncol. 2012; 30(2): 76-81.
     

  51. Ari MC, Buyuktas D, Eskazan AE, Ongoren Aydin S, Tanrikulu E, Baslar Z, Buyru AN, Ferhanoglu B, Aydin Y, Tuzuner N, Soysal T. The Association Between JAK2V617F Mutation and Bone Marrow Fibrosis at Diagnosis in Patients with Philadelphia-Negative Chronic Myeloproliferative Neoplasms. Turk J Haematol. 2012; 29(3): 242-7.
     

  52. Offner F, Ferhanoglu B, Reeves JA, Eom HS, Doner K, Raposo J, Flinn IW, Suh C, Chowhan NM, Prasad S, Kussick SJ, Mulligan G, Rizo A, Leonard JP. Phase 2 Studies of Immunochemotherapy +/- Bortezomib (Vc) in Newly Diagnosed Non-Germinal Center B-Cell-Like (Gcb) Dlbcl: Rapid Prospective Identification of Non-Gcb Patients (Pts). Ann Oncol. 2011; 22: 225-.
     

  53. Leonard J, Reeves J, Ferhanoglu B, Doner KT, Eom H, Flinn IW, Raposo J, Chowhan NM, Suh C, Noga S, Tumyan G, Aung S, Hajdenberg J, Ulrich BK, Pendergrass KB, Mulligan G, Rizo A, Kussick S, Offner F. PYRAMID and LYM2034: Targeted randomized phase II studies of bortezomib with or without immunochemotherapy in newly diagnosed nongerminal center B-cell-like (GCB) diffuse large B-cell lymphoma (DLBCL), including rapid prospective non-GCB subtype identification. J Clin Oncol. 2011; 29(15).
     

  54. Eskazan AE, Tatonyan SC, Salihoglu A, Gulturk E, Ar MC, Aydin SO, Baslar Z, Ferhanoglu AB, Tuzuner N, Aydin Y, Ozbek U, Soysal T. Multidrug Resistance Gene (MDR1) C3435T Polymorphism and Imatinib Response in Patients with Chronic Myeloid Leukemia. Blood. 2011; 118(21): 736-.
     

  55. Eskazan AE, Soysal T, Ongoren S, Gulturk E, Ferhanoglu B, Aydin Y. Pleural and pericardial effusions in chronic myeloid leukemia patients receiving low-dose dasatinib therapy. Haematologica. 2011; 96(3): e15; author reply e6-7.
     

  56. Eskazan AE, Soysal T, Erbilgin Y, Ozbek U, Ferhanoglu B. Chronic myeloid leukemia patients with F317L BCR-ABL kinase domain mutation are resistant to dasatinib: is that true for all the patients? Leuk Res. 2011; 35(9): e145-6.
     

  57. Eskazan AE, Ongoren S, Ar MC, Soysal T, Ferhanoglu B, Aki H, Aydin Y. Essential thrombocythemia and multiple myeloma: two rare diseases in one patient. Clin Lymphoma Myeloma Leuk. 2011; 11(5): 442-5.
     

  58. Eskazan AE, Akmurad H, Ongoren S, Ozer O, Ferhanoglu B. Primary gastrointestinal diffuse large B cell lymphoma presenting with cold agglutinin disease. Case Rep Gastroenterol. 2011; 5(2): 262-6.
     

  59. Arslan F, Tabak F, Avsar E, Midilli K, Mert A, Ozaras R, Soysal T, Ozturk R, Ferhanoglu B. Ganciclovir-resistant cytomegalovirus encephalitis in a hematopoietic stem cell transplant recipient. J Neurovirol. 2010; 16(2): 174-8.
     

  60. Ardeshna KM, Qian WD, Smith P, Warden J, Stevens L, Pocock CFE, Miall F, Cunningham D, Davies J, Walewski J, Ferhanoglu AB, Bradstock K, Linch DC. An Intergroup Randomised Trial of Rituximab Versus a Watch and Wait Strategy In Patients with Stage II, III, IV, Asymptomatic, Non-Bulky Follicullar Lymphoma (Grades 1, 2 and 3a). A Preliminary Analysis. Blood. 2010; 116(21): 5-.
     

  61. Ure U, Ar MC, Baslar Z, Soysal T, Ongoren S, Gulseven M, Aydin Y, Ulku B, Tuzuner N, Ferhanoglu B. The Effect of ZAP-70 Expression on Disease Progression in Early-Stage (Binet A) B-CLL Patients. Trak Univ Tip Fak De. 2009; 26(4): 317-21.
     

  62. Tarkan-Arguden Y, Ar MC, Yilmaz S, Ongoren S, Kuru D, Ure U, Cirakoglu A, Eskazan AE, Guven GS, Cetin G, Purisa S, Baslar Z, Deviren A, Aydin Y, Hacihanefioglu S, Ferhanoglu B, Tuzuner N, Ulku B, Soysal T. Cytogenetic Clonal Evolution in Patients with Chronic Myeloid Leukemia. Biotechnol Biotec Eq. 2009; 23(4): 1515-20.
     

  63. Saydam G, Haznedaroglu IC, Temiz Y, Soysal T, Sucak G, Tombuloglu M, Ozdogu H, Yavuz S, Altintas A, Ozet G, Gulbas Z, Ferhanoglu B, Ilhan O. Retrospective Evaluation of Patients Treated with Dasatinib for Philadelphia Positive Leukemias: Turkish Experience of 16 Months. Uhod-Uluslar Hematol. 2009; 19(4): 195-204.
     

  64. Ozer O, Eskazan AE, Ar MC, Bekoz H, Tabak F, Ongen G, Ferhanoglu B. Sarcoidosis mimicking lymphoma on positron emission tomography-computed tomography in two patients treated for lymphoma: two case reports. J Med Case Rep. 2009; 3: 7306.
     

  65. Ongoren S, Tarkan-Arguden Y, Ar MC, Yilmaz S, Ure U, Kuru D, Eskazan AE, Guven GS, Cetin G, Cirakoglu A, Baslar Z, Deviren A, Aydin Y, Hacihanefioglu S, Ferhanoglu B, Tuzuner N, Ulku B, Soysal T. Clonal Chromosomal Abnormalities in Philadelphia-Negative Cells and Their Clinical Significance in Patients with Chronic Myeloid Leukemia: Results of a Single Center. Turk Klin Tip Bilim. 2009; 29(2): 321-30.
     

  66. Ar MC, Ozbalak M, Tuzuner N, Bekoz H, Ozer O, Ugurlu K, Tabak F, Ferhanoglu B. Severe bone marrow failure due to valganciclovir overdose after renal transplantation from cadaveric donors: four consecutive cases. Transplant Proc. 2009; 41(5): 1648-53.
     

  67. Igdem S, Okkan S, Unalan B, Igdem A, Ferhanoglu B. Cervical cancer coexisting with small lymphocytic lymphoma detected during positron emission tomography/computed tomography simulation: a case report. Eur J Gynaecol Oncol. 2008; 29(4): 405-7.
     

  68. Erdogan EB, Guner SI, Sonmezoglu K, Ferhanoglu B, Halac M, Uslu I. Can post-treatment PET/CT scanning after first-line chemotherapy predict the prognosis in patients with Hodgkin disease and high-grade nonHodgkin lymphoma? Eur J Nucl Med Mol I. 2008; 35: S221-S.
     

  69. Ure UB, Ar MC, Salihoglu A, Guner SI, Baran A, Oguz O, Ferhanoglu B. Alemtuzumab in Sezary syndrome: efficient but not innocent. Eur J Dermatol. 2007; 17(6): 525-9.
     

  70. Üre Ü, Özer Ö, Beköz H, Tüzüner N, Ferhanoglu B. İmages 96: Hodgkin Lymphoma Presenting as a Palpable Scalp Mass. Bloodmed. 2007.
     

  71. Soer M, Ozbalak M, Senocak M, Soysal T, Ferhanoglu B, Molinas N, Tuzuner N. Prognostic significance of micro vessel density in diffuse large B cell lymphomas. Virchows Arch. 2007; 451(2): 357-8.
     

  72. Sili U, Yilmaz M, Ferhanoglu B, Mert A. Candida krusei arthritis in a patient with hematologic malignancy: successful treatment with voriconazole. Clin Infect Dis. 2007; 45(7): 897-8.
     

  73. Ozer O, Eskazan E, Bekoz H, Peker K, Yuksel S, Altiok E, Ferhanoglu B. A case of V617F(+) myelodysplastic/myeloproliferative disorder. Virchows Arch. 2007; 451(2): 434-.
     

  74. Hatirnaz O, Ure U, Ar C, Akyerli C, Soysal T, Ferhanoglu B, Ozcelik T, Ozbek U. The SOCS-1 gene methylation in chronic myeloid leukemia patients. Am J Hematol. 2007; 82(8): 729-30.
     

  75. Hatirnaz O, Ekmekci CG, Ar C, Ure U, Soysal T, Ferhanoglu B, Ozbek U. Detection of SOCS-1 (suppressor of cytokine signaling-1) methylation in CML (chronic myeloid leukemia) patients. Febs J. 2006; 273: 322-.
     

  76. Pamuk ON, Pamuk GE, Soysal T, Ongoren S, Baslar Z, Ferhanoglu B, Aydin Y, Ulku B, Aktuglu G, Akman N. Chronic lymphocytic leukemia in Turkey: experience of a single center in Istanbul. South Med J. 2004; 97(3): 240-5.
     

  77. Aki H, Tuzuner N, Ongoren S, Baslar Z, Soysal T, Ferhanoglu B, Sahinler I, Aydin Y, Ulku B, Aktuglu G. T-cell-rich B-cell lymphoma: a clinicopathologic study of 21 cases and comparison with 43 cases of diffuse large B-cell lymphoma. Leuk Res. 2004; 28(3): 229-36.
     

  78. Gurses N, Kalayoglu-Besisik S, Sargin D, Ferhanoglu B, Anak S, Soysal T, Baslar Z, Ongoren S, Bilgen H, Gedykoglu G, Aydin M, Abacy N, Gul A, Ozbek U. Interleukin-6 gene polymorphisms associate with acute graft-versus-host disease in HLA-matched allogeneic hematopoietic stem cell transplantation. Bone Marrow Transpl. 2003; 31: S129-S.
     

  79. Ferhanoglu B, Ongoren S, Ar CM, Uzel B, Forta H, Necioglu D. Intrathecal methotrexate-induced acute cerebellar syndrome. Ann Hematol. 2003; 82(4): 241-3.
     

  80. Akan H, Uzun O, Akova M, Senol E, Ozkalemkas F, Ferhanoglu B, Dincer S, Korten V. FUNGOBASE: An epidemiological study to determine the trends in antifungal treatment in Turkey. Trends in Medical Mycology. 2003: 43-7.
     

  81. Tiryakioglu O, Kadioglu P, Ongoren S, Acbay O, Ferhanoglu B, Gundoglu S, Korugan U. An unusual cause of hypercalcemia in polycythemia vera: parathyroid adenoma. Acta Med Okayama. 2002; 56(3): 167-70.
     

  82. Pamuk GE, Pamuk ON, Soysal T, Ongoren S, Baslar Z, Ferhanoglu B, Aydin Y, Ulku B, Aktuglu G, Akman N. An overview of young CLL patients: a single-centre experience from Turkey. Haematologia. 2002; 31(4): 303-11.
     

  83. Pamuk GE, Pamuk ON, Baslar Z, Ongoren S, Soysal T, Ferhanoglu B, Aydin Y, Ulku B, Aktuglu G, Akman N. Overview of 321 patients with idiopathic thrombocytopenic purpura. Retrospective analysis of the clinical features and response to therapy. Ann Hematol. 2002; 81(8): 436-40.
     

  84. Ozbek U, Gurses N, Kalayoglu-Besisik S, Aydin M, Bilgen H, Ongoren S, Yalman N, Anak S, Baslar Z, Soysal T, Ferhanoglu B, Gedikoglu G, Sargin D. The value of TNF-alpha and IL-10 gene polymorphisms in the incidence and severity of graft-versus-host disease. Bone Marrow Transpl. 2002; 29: S198-S.
     

  85. Ozbek U, Gurses N, Kalayoglu-Besisik S, Aydin M, Bilgen H, Ongoren S, Yalman N, Abaci N, Anak S, Baslar Z, Soysal T, Gul A, Ferhanoglu B, Aydin Y, Ulku B, Aktuglu G, Gedikoglu G, Sargin D. Cytokine gene polymorphism in patients with graft-versus-host disease after HLA-matched bone marrow transplantion. Blood. 2001; 98(11): 361b-b.
     

  86. Ferhanoglu AB, Acicbe O, Ongoren S, Tabak F, Baslar Z, Ozturk R, Soysal T, Mert A, Yilmaz M, Murtezaoglu A, Aydin Y, Ulku B, Aktuglu G, Aktuglu Y. Profile of microorganisms isolated from febrile neutropenic patients. Blood. 2001; 98(11): 26b-b.
     

  87. Erman M, Akova M, Akan H, Korten V, Ferhanoglu B, Koksal I, Cetinkaya Y, Uzun O, Unal S. Comparison of cefepime and ceftazidime in combination with amikacin in the empirical treatment of high-risk patients with febrile neutropenia: a prospective, randomized, multicenter study. Scand J Infect Dis. 2001; 33(11): 827-31.
     

  88. Soysal T, Pamuk ON, Pamuk GE, Ongoren S, Baslar Z, Ferhanoglu B, Aydin Y, Ulku B, Aktuglu G, Akman N. An overview of young CLL patients. Blood. 2000; 96(11): 294b-b.
     

  89. Pamuk GE, Pamuk ON, Baslar Z, Ongoren S, Soysal T, Ferhanoglu B, Aydin Y, UIku B, Aktuglu G, Akman N. A single center experience with 321 ITP patients. Blood. 2000; 96(11): 68b-9b.
     

  90. Giles FJ, Shan J, Advani SH, Akan H, Aydogdu I, Aziz Z, Azim HA, Bapsy PP, Buyukkececi F, Chaimongkol B, Chen PM, Cheong SK, Ferhanoglu B, Hamza R, Khalid HM, Intragumtornchai T, Kim SW, Kim SY, Koc H, Kumar L, Kumar R, Lei KI, Lekhakula A, Muthalib A, Patel M, Poovalingam VP, Prayoonwiwat W, Rana F, Reksodiputro AH, Ruff P, Sagar TG, Schwarer AP, Song HS, Suh CW, Suharti C, Supindiman I, Tee GY, Thamprasit T, Villalon AH, Wickham NR, Wong JE, Yalcin A, Jootar S. A prospective randomized study of Chop versus Chop plus alpha-2B interferon in patients with intermediate and high grade non-Hodgkin's lymphoma: the International Oncology Study Group NHL1 Study. Leuk Lymphoma. 2000; 40(1-2): 95-103.
     

  91. Demircioglu M, Ongoren S, Uzel B, Karadogan I, Aky H, Tuzuner N, Undar L, Ferhanoglu B. Comparison of flow cytometry with other methods in diagnosis of PNH. Blood. 2000; 96(11): 10b-b.
     

  92. Budak T, Besisik S, Akan H, Baslar Z, Ratip S, Koc H, Ferhanoglu B, Bayik M, Tangun Y. The prevalence of tuberculosis (TBC) in adult allogeneic stem cell transplant recipients in Turkey. Bone Marrow Transpl. 1999; 23: S123-S.
     

  93. Baslar Z, Ongoren S, Soysal T, Ferhanoglu B, Aktuglu G, Ulkii B. Extramedullary relapse after allogeneic stem cell transplantation. Bone Marrow Transpl. 1999; 23: S2-S.
     

  94. Aydingoz IE, Ferhanoglu B, Guney O. Does tissue iron status have a role in female alopecia? J Eur Acad Dermatol Venereol. 1999; 13(1): 65-7.
     

  95. Ulutin ON, Ulutin ŞB, Çizmeci G, T U, Ferhanoglu B. Some Clinical, Pharmacological Observations of the Effect of Defibrotide in Human. Acta Pharmaceutica Turcica. 1998; (30): 57-62.
     

  96. Soysal T, Baslar Z, Ferhanoglu B, Akman N. Donor leukocyte infusions for acute myeloid leukemia relapsing after stem cell transplantation. Acta Haematol. 1998; 99(1): 49-51.
     

  97. Baslar Z, Soysal T, Aygun G, Ferhanoglu B, Sarioglu AC, Ulku B. Successfully treated invasive central nervous system aspergillosis in an allogeneic stem cell transplant recipient. Bone Marrow Transpl. 1998; 22(4): 404-5.
     

  98. Ozen S, Ferhanoglu B, Senocak M, Tuzuner N. Idiopathic myelofibrosis (agnogenic myeloid metaplasia): clinicopathological analysis of 32 patients. Leuk Res. 1997; 21(2): 125-31.

  99. Ozbek U, Vural B, Kalayoglu S, Soysal T, Bilgen H, Yavuz S, Anak S, Sargin D, Gedikoglu G, Ferhanoglu B, Akoglu T, Tangun Y, Ozcelik T. Evaluation of chimerism with DNA polymorphisms in bone marrow transplantation. Turk J Pediatr. 1997; 39(3): 303-11.
     

  100. Ferhanoglu B, Erzin Y, Baslar Z, Tuzuner HA. Secondary amyloidosis in the course of idiopathic myelofibrosis. Leuk Res. 1997; 21(9): 897-8.
     

  101. Baslar Z, Soysal T, Hanci M, Aygun G, Ferhanoglu B, Sarioglu AC, Ulku B. Successful outcome of aspergillus brain abscess in a patient who underwent bone marrow transplantation for aplastic anemia. Haematologia. 1997; 28(4): 265-71.
     

  102. Başlar Z, Tüfekçi IB, Soysal T, Ferhanoğlu B, Aydın Y, Aktuğlu G, Akman N , B Ü. Neutropenic Enterocolitis In Acute Leukemia. Turkish Journal Of Haematology. 1997; (14): 109-12.
     

  103. Ulutin ON, Balkuv-Ulutin S, Bezer-Goker B, Cizmeci G, Ferhanoglu B, Ozsoy Y, Ugur MS, Ulutin T, Yaman A, Yardimci T. Effect of defibrotide on platelet function. Semin Thromb Hemost. 1996; 22 Suppl 1: 21-4.
     

  104. Sayman HB, Sonmezoglu K, Altiok E, Devranoglu G, Ferhanoglu B. Unexpected bone marrow uptake of thallium-201 in nonsecretory myeloma. J Nucl Med. 1995; 36(2): 250-1.

  105. Soysal T, Ferhanoglu B, Bilir M, Akman N. Oculomotor nerve palsy associated with vincristine treatment. Acta Haematol. 1993; 90(4): 209-10.
     

  106. Ertugrul H, Aydemir A, Ferhanoglu B, Oğuz O, Akçakaya N, Tozakı S, Avanoglu Y, Y G. Hyper IgE Syndrome Amiloidosis and Developmental Defect. Turkish Journal of Medical and Biological Research. 1992; (3): 305-9.
     

  107. Wu KK, Sanduja R, Tsai AL, Ferhanoglu B, Loose-Mitchell DS. Aspirin inhibits interleukin 1-induced prostaglandin H synthase expression in cultured endothelial cells. Proc Natl Acad Sci U S A. 1991; 88(6): 2384-7.
     

  108. Ulutin ON, Ulutin SB, Ugur MS, Ulutin T, Erbengi T, Ferhanoglu B, T Y. Defibrotide and its Effects on Platelet Function. In: Thrombosis and Haemorrhagic Disorders. In: Vinazzer HSaH, ed. Schimmitt and Meyer GmBH Winzburg; 1989. p. 426-28.
     

  109. Ulutin ON, Ulutin SB, Çizmeci G, T U, Ferhanoglu B. Some Clinical, Pharmacological Observations of the Effect of Defibrotide in Human. Acta Pharmaceutica Turcica. 1988; (30): 57-62.
     

bottom of page